Hepatocellular carcinoma (surveillance)

Hepatocellular carcinoma surveillance programs have been adopted by some health systems in attempts to effect an early diagnosis of hepatocellular carcinoma in high-risk populations. 

Rationale

The idea behind hepatocellular carcinoma screening, as with any screening program, is to detect clinically silent cancer earlier when treatment should have a better prognosis.

Current recommendations

Current recommendations for surveillance derive from a 2004 randomised controlled trial conducted in China with patients with chronic hepatitis B 1:

  • ultrasound exam + AFP serum test every 6 months

The group reported a 37% decrease in hepatocellular carcinoma mortality with this surveillance protocol, and this was attributed to early detection of tumours.

The six-month interval was based on the doubling time of hepatocellular carcinoma (median 4-6 months). Some data suggest that it is more optimal than a 3 month or 12-month interval 2,3.

AASLD and EASL guidelines

American Association for the Study of Liver Disease (AASLD) and the European Association for the Study of the Liver (EASL) promote ultrasound every 6 months if: 4,5

  • hepatitis B
    • men >40 years old
    • women >50 year old
    • Africans >20 years old and at time of diagnosis if there is a positive family history
  • hepatitis C
    • if stage 3 fibrosis

Surveillance is not recommended for patients who are too decompensated to benefit from therapy if a tumour is found.

Controversies
  • the surveillance protocol from the experiment may not be generalizable to other patient populations in the world, but the likelihood of being able to conduct a randomised controlled trial in Western nations is low 6
  • data for CT or MRI as screening modalities has not been well developed
  • unlike the original screening trial, AFP is not currently included in screening guidelines because of problems with sensitivity and specificity
    • persistently increasing AFP or increasing AFP with stable AST are concerning for hepatocellular carcinoma
    • AFP should never be the sole screening tool
Share article

Article information

rID: 34360
Synonyms or Alternate Spellings:
  • HCC screening
  • Hepatocellular carcinoma (HCC) screening
  • HCC surveillance

Support Radiopaedia and see fewer ads

Updating… Please wait.
Loadinganimation

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.